Completed OBSERVATIONAL NCT01490684

Invasive Candidiasis in Saudi ICUs (ICIP-SA)

Invasive Candidiasis in Critically Ill Patients in Saudi Arabia: A Prospective Cohort Study

Sponsor: Hasan Al-Dorzi

Updated 9 times since 2017 Last updated: Nov 30, 2017 Started: Aug 31, 2012 Primary completion: May 31, 2016 Completion: May 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01490684, this observational or N/A phase trial focuses on Invasive Candidiasis and remains completed. Sponsored by Hasan Al-Dorzi, it has been updated 9 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2023 — Jul 2024 [monthly]

Completed
Dec 2022 — Jan 2023 [monthly]

Completed
Jan 2021 — Dec 2022 [monthly]

Completed

▶ Show 4 earlier versions

Sep 2018 — Jan 2021 [monthly]

Completed

Status: Unknown Status → Completed
Jun 2018 — Sep 2018 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hasan Al-Dorzi
King Fahad Medical City

Data source: King Abdulaziz Medical City

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Riyadh, Saudi Arabia